Therefore, five publications [7,11,18-20], consisting of six individual studies with a total of 4,043 subjects (1,796 cases, 2,247 controls) regarding association of COMT Val158Met polymorphism with lung cancer risk were included in this meta-analysis. Here, COMT is linked to lung carcinoma.